3653 results for «414»
3653 results
Uncommon complications in NSTEMI
22 Sep 2023 – From AICT-AsiaPCR 2023
Discoversome unforeseen challenges in NSTEMI cases in this session, ranging from managing coronary air embolisms and distinguishing between inflammation and infarction to dealing with coronary aneurysms at the left main coronary artery bifurcation and addressing type 5 coronary perforation.
Advanced techniques for managing calcified lesions
22 Sep 2023 – From AICT-AsiaPCR 2023
Discover advanced strategies for tackling complex calcified lesions in this session: from innovative approaches like the 'Orbital-shock' technique to managing calcified lesions in patients with previous CABG and in-stent restenosis, and exploring calcium modification strategies tailored to specific cases, these presentations offer valuable insights into simplifying...
Complex CTO challenges
22 Sep 2023 – From AICT-AsiaPCR 2023
Gain valuable insights into overcoming CTO challenges in this session: learn how IVUS can come to the rescue in cases of main branch cut-off, discover successful recanalization techniques for right coronary artery CTOs using very long epicardial channels and explore the best approaches for managing complex...
Learning - Cardiogenic shock
22 Sep 2023 – From AICT-AsiaPCR 2023
Explore the complexities of cardiogenic shock management in this session: understand its pathophysiology, learn about the role of mechanical support (IABP, Impella, ECMO) in addition to pharmacological treatment, gather tips and tricks from expert speakers and gain insights into real-world cases.
Other valvular interventions
22 Sep 2023 – From AICT-AsiaPCR 2023
Explore innovative approaches to various valvular interventions in this session: from managing post-mitral valve replacement complications and performing balloon mitral valvotomy in patients with restenosis after mitral valve interventions to tackling calcified mitral valves and addressing unique cases like LBB pacing in isolated ccTGA with complete...
Advanced approaches to treating calcified lesions
22 Sep 2023 – From AICT-AsiaPCR 2023
Discover advanced insights into calcified lesions in this session, covering topics such as: managing double disasters, treating severe calcified left main disease, addressing complications in double vessel rotablation with left main bifurcation stenting, and using rotatripsy in OCT-guided PCI for calcified left anterior descending artery.
How to manage complications in CTO PCI
22 Sep 2023 – From AICT-AsiaPCR 2023
Explore complex CTO PCI scenarios and gain insights into complications and their solutions in this session. Topics include CTO vessel rupture after a covered stent bailout, epicardial channel perforation management, dissection from collateral tip injection, and more!
Spontaneous coronary artery disease, INOCA, MINOCA in women
21 Sep 2023 – From AICT-AsiaPCR 2023
Consult this session to better understand the causes of myocardial infarction without obstructive disease (MINOCA), to revisit ischemia with no obstructive coronary atherosclerosis (INOCA), and to broaden your understanding of spontaneous coronary artery dissection (SCAD) beyond its association with pregnancy.
Innvolution Healthcare reports one-year findings from the ALCHEMY study evaluating Eternia in 1000 patients at EuroPCR 2026
27 May 2026
Four-Year Outcomes from the EVOLUT Low Risk Trial
26 Oct 2023
Dejan Milasinovic provides his take on the EVOLUT Low Risk trial, presented by Michael I. Reardon at TCT Congress 2023. 4-year results reveal a continuing trend towards lower combined rates of all-cause mortality and disabling stroke with TAVI compared with surgical aortic valve replacement (SAVR)
Author
5-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis (Evolut Low Risk)
01 Apr 2025
Yohei Ohno provides his takeaways from the results of the Evolut Low Risk trial which was presented by Michael J. Reardon during the ACC.25 in Chicago.
Author
Cardiac biomarkers in patients with asymptomatic severe aortic stenosis: primary biomarker analysis from the EARLY TAVR Trial
01 Apr 2025
Elad Asher provides his take on the primary biomarker analysis from the EARLY TAVR Trial presented by Brian R. Lindman at ACC.25 in Chicago.
Author
Transcatheter vs surgical aortic valve replacement in aortic stenosis patients at low surgical risk: 3-year outcomes from the Evolut Low Risk trial
05 Mar 2023
Luigi Biasco provides his take on the clinical trial presented by John K. Forrest from Yale University School of Medicine, New Haven, Connecticut, USA during the 2023 ACC/WCC annual congress held in New Orleans, Louisiana.
Author
